Sage Journals: Discover world-class research

Free access

Review article

First published 2012-4

Safety and efficacy of subcutaneous formulation of bortezomib versus the conventional intravenous formulation in multiple myeloma

Marìa-Victoria Mateos, Jesús F. San Miguel

Therapeutic Advances in Hematology

Retricted access

Case report

First published 2016-5

Successful treatment of systemic lupus erythematosus with subcutaneous immunoglobulin

A Brasileiro, J Fonseca Oliveira, S Pinheiro [...]

Lupus

Open access

Research article

First published 2025

Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis

Marc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2018

Assessing social and economic impact of subcutaneous mAbs in oncology

Americo Cicchetti, Silvia Coretti, Daniele Mascia [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Review article

First published 2021

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma

Larysa Sanchez, Joshua Richter, Hearn Jay Cho [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2025-4

Evaluation of cost and infusion-related reactions among intravenous trastuzumab,subcutaneous trastuzumab,and trastuzumab biosimilars at an academic medical center

Daijah M Davis, Kasey Jackson, Christina Hoppe

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2006-2

Erythropoietin Dose Requirements When Converting from Subcutaneous to Intravenous Administration Among Patients on Hemodialysis

Louise M Moist, Norm Muirhead, Lori D Wazny [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2021-6

Patient preferences for systemic sclerosis treatment: A descriptive study within an Italian cohort

Khadija El Aoufy, Cosimo Bruni, Laura Rasero [...]

Journal of Scleroderma and Related Disorders

Open access

Review article

First published 2024

Take vedolizumab home: transition from intravenous to subcutaneous treatment

Kaituo Huang, Lingya Yao, Jing Liu [...]

Sage Open Chronic Disease

Retricted access

Review article

First published 2023-3

Pharmacokinetic characterization,benefits and barriers of subcutaneous administration of monoclonal antibodies in oncology

Ana Homšek, Jelena Spasić, Neda Nikolić [...]

Journal of Oncology Pharmacy Practice

Search results